Stereotaxis designs, manufactures, and markets robotic systems and information platforms for interventional medical procedures, with a core focus on cardiac electrophysiology and arrhythmia treatment. The company's proprietary Robotic Magnetic Navigation technology uses computer-controlled magnetic fields to guide flexible catheters with greater precision, stability, and safety than manual alternatives, serving hospital interventional labs across major markets worldwide. Stereotaxis generates revenue through capital equipment sales, recurring disposable costs per procedure, and service and software maintenance contracts, while pursuing expansion into additional endovascular applications such as coronary and neurovascular interventions.